ESR1 and breast carcinoma: However, more recently, there is a high level of evidence suggesting that in the population of older women with stage 1 breast cancer, ER/PR positive and HER2 negative, the gains in ipsilateral local control are small, while other parameters, such as contralateral breast development, regional failures, and overall survival, are unchanged by the omission of adjuvant WBRT [3].